IL1B and Parkinson disease: Interestingly, VIP and SST are implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease (PD) through reducing the production of inflammatory mediators such as TNF-α and IL-1β [21].